Pascaline Berthet

Risks of Breast, Ovarian, and Contralateral Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers

Karoline Kuchenbaecker, John L. Hopper, Daniel R. Barnes et al. · JAMA · 2017 · 2.9K citations · Full text

Medicine, Genetics, Oncology +17

Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

Fergus J. Couch, Xianshu Wang, Lesley McGuffog et al. · PLoS Genetics · 2013 · 391 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial

Rafael Rosell, U. Gatzemeier, Daniel Betticher et al. · Annals of Oncology · 2002 · 302 citations · Full text

Medicine, Oncology, Pharmacology +11

Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes

Laurent Castéra, Sophie Krieger, Antoine Rousselin et al. · European Journal of Human Genetics · 2014 · 257 citations

Medicine, Genetics, Oncology +17

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Implications for Risk Prediction

Antonis C. Antoniou, Jonathan Beesley, Lesley McGuffog et al. · Cancer Research · 2010 · 184 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17